Details
This activity is supported by educational grants from Alcon Laboratories Inc., Carl Zeiss Meditec, and Johnson & Johnson Vision.
Credits: By completing this activity you will earn 1.0 AMA PRA Category 1 Credit™.
Activity Expiration Date: July 31, 2019
Faculty: Daniel H. Chang, MD, Nicole R. Fram, MD, Terry Kim, MD, and Elizabeth Yeu, MD.
Learning Objectives
Ophthalmologists who attend this course will:
- Describe the progressive nature of age-related changes to the crystalline lens from onset of presbyopia through development of cataract, and compare and contrast presbyopia treatment options to match solutions to patients’ needs at various points along that continuum
- Compare risks and benefits of treatment with and without presbyopia-correcting IOLs, including potential impact on patient lifestyle
- Analyze evidence-based data on quality of vision, visual symptoms, and range of vision with various approaches to presbyopia correction and implement appropriate thresholds for acceptable pseudophakic refractive error levels with each
- Identify steps to mitigate refractive surprises and manage postoperative dissatisfaction to increase postoperative success